Moreover, Rac1 gain-of-function mutations have been identified in recent years, such as the two somatic mutations Rac1P29S and Rac1A159V, respectively detected in melanoma and in head-and-neck cancers [44,45,46], and occasionally observed in colon, thyroid, and lung cancers [47]. The gene discussed is RAC1; the disease is melanoma.